Company profile
BPGbio, Inc.
#biopharma #therapeutics #mitochondrial #oncology #neurology #raredisease #drugdiscovery #glioblastoma #PCQD
- Industry
- Biotechnology Research
- Employees
- 65
- Headquarters
- Waltham, Massachusetts
- Founded
- 2006
- LinkedIn followers
- 9,070
- Office locations
- 1
BPGbio, Inc. company summary
BPGbio, Inc. is a company in the Biotechnology Research industry, headquartered in Waltham, Massachusetts, founded in 2006. On LinkedIn the company has around 65 employees and 9,070 followers. Its listed specialties include Biotechnology, rare diseases, Oncology, Neurology, mitochondrial.
What technology does BPGbio, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About BPGbio, Inc.
BPGbio is a clinical-stage biopharmaceutical company focused on developing mitochondrial-targeted therapies for patients. The company’s approach is grounded in advancing therapeutics that restore cellular energy regulation and address mitochondrial dysfunction, a central driver of disease across multiple high-burden indications. BPGbio’s lead clinical candidate, BPM31510, is a potential first-in-class mitochondrial metabolic modulator currently in clinical development for Primary CoQ10 Deficiency (PCQD) and Glioblastoma. The asset has also completed a phase I trial in Epidermolysis Bullosa (EB). The company is currently exploring the potential of BPM31510 in small cell carcinoma (SCC), pancreatic cancers, and sarcopenia.
Specialties
Where is BPGbio, Inc. located?
BPGbio, Inc. lists 1 location.
Compare companies similar to BPGbio, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
BPGbio, Inc. bpgbio.com | Biotechnology Research | 65 | 2006 | Waltham, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about BPGbio, Inc.
What does BPGbio, Inc. do?
BPGbio is a clinical-stage biopharmaceutical company focused on developing mitochondrial-targeted therapies for patients. The company’s approach is grounded in advancing therapeutics that restore cellular energy regulation and address mitochondrial dysfunction, a central driver of disease across multiple high-burden indications. BPGbio’s lead clinical candidate, BPM31510, is a potential first-in-class mitochondrial metabolic modulator currently in clinical development for Primary CoQ10 Deficiency (PCQD) and Glioblastoma. The asset has also completed a phase I trial in Epidermolysis Bullosa (EB). The company is currently exploring the potential of BPM31510 in small cell carcinoma (SCC), pancreatic cancers, and sarcopenia.
How many employees does BPGbio, Inc. have?
BPGbio, Inc. has around 65 employees on LinkedIn.
Where is BPGbio, Inc. headquartered?
BPGbio, Inc. is headquartered in Waltham, Massachusetts.
When was BPGbio, Inc. founded?
BPGbio, Inc. was founded in 2006.
Build a lead list from companies like BPGbio, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.